Phibro Animal Health Corporation
PAHC
$41.88
-$1.35-3.12%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.40B | 1.30B | 1.19B | 1.11B | 1.05B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.40B | 1.30B | 1.19B | 1.11B | 1.05B |
| Cost of Revenue | 956.65M | 890.59M | 806.46M | 752.12M | 717.38M |
| Gross Profit | 443.03M | 405.62M | 384.23M | 353.96M | 329.38M |
| SG&A Expenses | 279.36M | 269.33M | 261.75M | 250.72M | 240.66M |
| Depreciation & Amortization | 2.38M | 2.38M | 2.99M | 2.99M | 2.99M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.24B | 1.16B | 1.07B | 1.01B | 961.02M |
| Operating Income | 161.29M | 133.91M | 119.49M | 100.25M | 85.74M |
| Income Before Tax | 94.64M | 67.99M | 50.55M | 33.79M | 32.52M |
| Income Tax Expenses | 26.82M | 19.73M | 18.76M | 14.47M | 15.11M |
| Earnings from Continuing Operations | 67.82 | 48.26 | 31.79 | 19.32 | 17.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 67.82M | 48.26M | 31.79M | 19.32M | 17.41M |
| EBIT | 161.29M | 133.91M | 119.49M | 100.25M | 85.74M |
| EBITDA | 209.30M | 178.10M | 160.45M | 137.79M | 120.62M |
| EPS Basic | 1.67 | 1.19 | 0.78 | 0.48 | 0.43 |
| Normalized Basic EPS | 1.73 | 1.44 | 1.19 | 0.84 | 0.75 |
| EPS Diluted | 1.66 | 1.18 | 0.78 | 0.47 | 0.43 |
| Normalized Diluted EPS | 1.72 | 1.43 | 1.18 | 0.84 | 0.75 |
| Average Basic Shares Outstanding | 162.06M | 162.03M | 162.03M | 162.01M | 162.01M |
| Average Diluted Shares Outstanding | 163.00M | 162.71M | 162.61M | 162.42M | 162.21M |
| Dividend Per Share | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
| Payout Ratio | 28.69% | 40.30% | 61.17% | 100.64% | 111.70% |